Clincosm LogoSign in Get a demo

primary central nervous system lymphoma

Showing 26 - 46 of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary CNS Lymphoma Trial in Zhengzhou (Rituximab, Lenalidomide, Methotrexate)

Recruiting
  • Primary Central Nervous System Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jan 30, 2021

Primary CNS Lymphoma, Secondary CNS Lymphoma Trial (F520)

Not yet recruiting
  • Primary Central Nervous System Lymphoma
  • Secondary Central Nervous System Lymphoma
  • (no location specified)
Oct 19, 2020

Primary CNS Lymphoma Trial in Beijing (Methotrexate, Rituximab, Lenalidomide)

Recruiting
  • Primary Central Nervous System Lymphoma
  • Beijing, Dongcheng District, China
    Daobin Zhou
Jun 3, 2020

Non-Hodgkins Lymphoma, B-cell Lymphoma, Waldenstrom's Macroglobulinemia Trial in United States (Ublituximab)

Completed
  • Non-Hodgkins Lymphoma
  • +6 more
  • Huntsville, Alabama
  • +7 more
Oct 1, 2019

Primary CNS Lymphoma Trial in Zhengzhou (rituximab in combination with methotrexate, cytarabine and dexamethasone)

Recruiting
  • Primary Central Nervous System Lymphoma
  • rituximab in combination with methotrexate, cytarabine and dexamethasone
  • Zhengzhou, Henan, China
    Oncology Department of The First Affiliated Hospital of Zhengzho
Sep 5, 2019

Primary CNS Lymphoma Trial in Hwasun (IBER salvage chemo followed by ibrutinib maintenance therapy)

Not yet recruiting
  • Primary Central Nervous System Lymphoma
  • IBER salvage chemotherapy followed by ibrutinib maintenance therapy
  • Hwasun, Jeollanam-do, Korea, Republic of
    Chonnam National University Hwasun Hospital
Aug 22, 2019

Primary CNS Lymphoma Trial (PQR309)

Completed
  • Primary Central Nervous System Lymphoma
  • (no location specified)
Jul 3, 2019

Primary CNS Lymphoma Trial in France (cranial radiotherapy, intensive chemo and hematopoietic stem cell rescue, MTX based chemo)

Active, not recruiting
  • Primary Central Nervous System Lymphoma
  • cranial radiotherapy
  • +2 more
  • Amiens, France
  • +22 more
Feb 4, 2019

Primary CNS Lymphoma Trial in France (PQR309)

Withdrawn
  • Primary Central Nervous System Lymphoma
  • Marseille, France
  • +3 more
Nov 14, 2018

Primary CNS Lymphoma, Autologous Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Busulfan (BU),

Unknown status
  • Primary Central Nervous System Lymphoma
  • +2 more
  • Busulfan (BU)
  • +2 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Nov 6, 2018

Lymphoma, Primary CNS Lymphoma, Recurrent/Refractory Secondary CNS Lymphoma Trial in United States (Buparlisib (BKM120))

Completed
Has Results
  • Lymphoma
  • +2 more
  • Buparlisib (BKM120)
  • Basking Ridge, New Jersey
  • +3 more
Sep 20, 2017

Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission

Completed
Has Results
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +178 more
  • fludarabine phosphate
  • +5 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Apr 17, 2017

Diffuse Large B-cell Lymphoma, Indolent Non-hodgkin Lymphoma, Primary CNS Lymphoma Trial in France (Vismodegib)

Terminated
  • Diffuse Large B-cell Lymphoma
  • +3 more
  • Creteil, France
  • +9 more
Mar 8, 2017

Primary CNS Lymphoma Trial in Australia, New Zealand (Idarubicin, Methotrexate, Filgrastim, intrathecal Ara-C, Radiation

Completed
  • Primary Central Nervous System Lymphoma
  • Idarubicin, Methotrexate, Filgrastim, intrathecal Ara-C
  • Radiation Therapy
  • Garran, Australian Capital Territory, Australia
  • +14 more
Feb 15, 2017

Primary CNS Lymphoma Trial in United States (Rituximab plus Temozolomide)

Terminated
Has Results
  • Primary Central Nervous System Lymphoma
  • Rituximab plus Temozolomide
  • New Haven, Connecticut
  • +3 more
Dec 14, 2016

Primary CNS Lymphoma Trial in Beijing (ketogenic diet, Routine diet)

Unknown status
  • Primary Central Nervous System Lymphoma
  • ketogenic diet
  • Routine diet
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Dec 2, 2016

Primary CNS Lymphoma Trial in Vienna (pembrolizumab)

Unknown status
  • Primary Central Nervous System Lymphoma
  • Vienna, Austria
    Dept of Internal Medicine
Jun 21, 2016

Primary CNS Lymphoma Trial in Beijing (R-MT followed by auto-HSCT)

Unknown status
  • Primary Central Nervous System Lymphoma
  • R-MT followed by auto-HSCT
  • Beijing, Beijing, China
    Lijuan Deng
Apr 10, 2015

Primary CNS Lymphoma Trial in Houston (antineoplaston A10, antineoplaston AS2-1, alternative product therapy)

Withdrawn
  • Primary Central Nervous System Lymphoma
  • antineoplaston A10
  • +7 more
  • Houston, Texas
    Burzynski Clinic
Jul 9, 2013

Primary CNS Lymphoma Trial (Pemetrexed)

Withdrawn
  • Primary Central Nervous System Lymphoma
  • (no location specified)
Sep 16, 2011

Primary CNS Lymphoma Trial in Taiwan (Methotrexate, Methylprednisolone, Temozolomide)

Unknown status
  • Primary Central Nervous System Lymphoma
  • Changhua, Taiwan
  • +3 more
Apr 3, 2007